In AD, reduced Kir4.1 expression has been observed in postmortem brain samples with amyloid accumulation and mouse models of AD, suggesting a link between Kir4.1 dysfunction and AD pathology (Wilcock et al. 2009). Here, KCNJ10 is linked to amyloidosis.